Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/24922| Title: | The long-term impact of beta-lactam antibiotic allergy testing - A matched case-control study. | Austin Authors: | Trubiano, Jason ;Marhoon, Nada ;Vogrin, Sara;Chua, Kyra Y L ;Holmes, Natasha E | Affiliation: | Centre for Antibiotic Allergy and Research Data Analytics Research and Evaluation (DARE) Centre Medicine (University of Melbourne) Infectious Diseases Centre for Integrated Critical Care, University of Melbourne, Melbourne, Australia The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia |
Issue Date: | 28-Sep-2020 | Date: | 2020-09-28 | Publication information: | Antimicrobial Agents and Chemotherapy 2020; online first: 28 September | Abstract: | Whilst the short-term impact of antibiotic allergy testing on delabeling and antibiotic usage have been demonstrated, the long-term impact have been less well defined. In a single centre matched case control study from Melbourne (Australia), we demonstrate a beta-lactam antibiotic allergy testing program has a significant impact on antibiotic usage and infection-related outcomes. This study supports the implementation of antibiotic allergy testing program (AAT) as a standard of care of antimicrobial stewardship (AMS) programs. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/24922 | DOI: | 10.1128/AAC.01823-20 | ORCID: | 0000-0002-5111-6367 | Journal: | Antimicrobial Agents and Chemotherapy | PubMed URL: | 32988819 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.